Methyl jasmonate increases the production of valepotriates by transformed root cultures of Valerianella locusta

by Kittipongpatana N., Davis D.L., Porter J.R.
Published 2014

Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma

by Srichairatanakool S., Thephinlap C., Phisalaphong C., Porter J.B., Fucharoen S.
Published 2014

Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice

by Thephinlap C., Phisalaphong C., Fucharoen S., Porter J.B., Srichairatanakool S.
Published 2014

Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice

by Saewong T., Ounjaijean S., Mundee Y., Pattanapanyasat K., Fucharoen S., Porter J., Srichairatanakool S.
Published 2017

Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stress

by Thephinlap C., Ounjaijean S., Khansuwan U., Fucharoen S., Porter J.B., Srichairatanakool S.
Published 2014

Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay

by Garbowski M., Ma Y., Fucharoen S., Srichairatanakool S., Hider R., Porter J.
Published 2017

Effect of green tea on iron status and oxidative stress in iron-loaded rats

by Ounjaijean S., Thephinlap C., Khansuwan U., Phisalapong C., Fucharoen S., Porter J.B., Srichairatanakool S.
Published 2014

Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded mice

by Chansiw N., Pangjit K., Phisalaphong C., Porter J.B., Evans P., Fucharoen S., Srichairatanakool S.
Published 2014

Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded mice

by Chansiw,N., Pangjit,K., Phisalaphong,C., Porter,J.B., Evans,P.J., Fucharoen,S., Srichairatanakool,S.
Published 2015

Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids

by Thephinlap C., Phisalaphong C., Lailerd N., Chattipakorn N., Winichagoon P., Vadolus J., Fucharoen S., Porter J.B., Srichairatanakool S.
Published 2014

Measuring teamwork performance: Validity testing of the Team Emergency Assessment Measure (TEAM) with clinical resuscitation teams

by Cooper S., Cant R., Connell C., Sims L., Porter J.E., Symmons M., Nestel D., Liaw S.Y.
Published 2018

Insights into relationships between serum ferritin and liver iron concentration trends during 12 months of iron chelation therapy with deferasirox - a post-hoc analysis from the ep...

by Porter, J.B., Elalfy, M., Taher, A.T., Chan, L.L., Lee, S.H., Sutcharitchan, P., Aydinok, Y., Chakravarty, S., El-Ali, A., El-Beshlawy, A.
Published 2014

Integrin à2?1 expression regulates matrix metalloproteinase-1-dependent bronchial epithelial repair in pulmonary tuberculosis

by Brilha S., Chong D.L.W., Khawaja A.A., Ong C.W.M., Guppy N.J., Porter J.C., Friedland J.S.
Published 2019

Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C

by Cappellini, M.D., Elalfy, M., El-Beshlawy, A., Kattamis, A., Chan, L.L., Li, C., Lin, K.H., Quarta, G., Sutcharitchan, P., Taher, A., Habr, D., Roubert, B., Porter, J.
Published 2010

Continued improvement in cardiac T2*with deferasirox treatment over 2 years: Results from the extension of epic cardiac substudy in beta-thalassaemia patients with myocardial sider...

by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.
Published 2010

Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone t...

by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.
Published 2010

Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years

by Pennell, D., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, Chi-Kong, Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Published 2010

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia

by Pennell, D.J., Porter, J.B., Cappellini, M.D., El-Beshlawy, A., Chan, L.L., Aydinok, Y., Elalfy, M.S., Sutcharitchan, P., Li, C.K., Ibrahim, H., Viprakasit, V., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Published 2010

Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis

by Ong C.W.M., Elkington P.T., Brilha S., Ugarte-Gil C., Tome-Esteban M.T., Tezera L.B., Pabisiak P.J., Moores R.C., Sathyamoorthy T., Patel V., Gilman R.H., Porter J.C., Friedland J.S.
Published 2019

Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

by Cappellini, M.D., Porter, J., El-Beshlawy, A., Li, C.K., Seymour, J.F., Elalfy, M., Gattermann, N., Giraudier, S., Lee, J.W., Chan, L.L., Lin, K.H., Rose, C., Taher, A., Thein, S.L., Viprakasit, V., Habr, D., Domokos, G., Roubert, B., Kattamis, A., Investigators, EPIC Study
Published 2010